Gilead’s Remdesivir supply to be produced by 6 Indian companies

iNDICA NEWS BUREAU- To boost the supply of remdesivir — an experimental drug that has shown promise in treating Covid-19 — its maker, US-based Gilead Sciences, has signed non-exclusive voluntary licensing agreements with at least six Indian pharmaceutical companies. These companies are — Dr. Reddy’s Laboratories Ltd., Zydus Cadila Healthcare Ltd., Biocon company Syngene, Hetero […]

HCQ for COVID-19: New study casts doubts

indica News Bureau- A new study has added to the debate raging over the efficacy of the anti-malarial drug hydroxychloroquine or HCQ as preventive medicine against COVID-19. The new study, published on Wednesday in the New England Journal of Medicine, concluded: “After high-risk or moderate-risk exposure to Covid-19, hydroxychloroquine did not prevent illness compatible with COVID-19 […]